It could be seen in Figure 9 that the expressions of BCL6, CD44, HMOX1 IL4R, ITGA5, and SOCS3 in AD patients were significantly up-regulated, which was consistent with GSE110226. This evidence concerns the gene BCL6 and Alzheimer disease.